List of Schedule I controlled substances (U.S.) explained

This is the list of Schedule I controlled substances in the United States as defined by the Controlled Substances Act.[1] The following findings are required for substances to be placed in this schedule:[2]

  1. The drug or other substance has a high potential for abuse.
  2. The drug or other substance has no currently accepted medical use in treatment in the United States.
  3. There is a lack of accepted safety for use of the drug or other substance under medical supervision.

The complete list of Schedule I substances is as follows.[1] The Administrative Controlled Substances Code Number for each substance is included.

Opioids

Drug
9815Acetyl-alpha-methylfentanyl[3]
9601Acetylmethadol[4]
9821Acetylfentanyl[5]
9811Acryl fentanyl[6]
9551AH-7921[7]
9602Allylprodine
9603Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM)[8]
9604Alphameprodine
9605Alphamethadol
9814Alpha-methylfentanyl[9]
9832Alpha-methylthiofentanyl
9606Benzethidine
9607Betacetylmethadol
9830Beta-hydroxyfentanyl
9831Beta-hydroxy-3-methylfentanyl[10]
9836Beta-hydroxythiofentanyl[11]
9608Betameprodine
9609Betamethadol
9856Beta-methylfentanyl[12]
9842Beta-phenylfentanyl
9611Betaprodine
9098Brorphine[13]
9822Butyryl Fentanyl[14]
9612Clonitazene
9844Crotonylfentanyl[15]
9847Cyclopentyl fentanyl[16]
9845Cyclopropyl fentanyl[17]
9613Dextromoramide
9615Diampromide
9616Diethylthiambutene
9168Difenoxin[18]
9617Dimenoxadol
9618Dimepheptanol
9619Dimethylthiambutene
9621Dioxaphetyl butyrate
9622Dipipanone
9623Ethylmethylthiambutene
9624Etonitazene
9625Etoxeridine
9851Fentanyl carbamate[19]
98244-Fluoroisobutyryl fentanyl
98552′-Fluoro ortho-fluorofentanyl
9834Furanyl fentanyl
9626Furethidine
9627Hydroxypethidine
9827Isobutrylfentanyl
9614Isotonitazene[20]
9628Ketobemidone
9629Levomoramide
9631Levophenacylmorphan
9825Methoxyacetyl fentanyl
98194′-Methyl acetyl fentanyl
98133-Methylfentanyl
9833
9757Metonitazene[21]
9632Morpheridine
9661MPPP[22]
9560MT-45[23]
9633Noracymethadol
9634Norlevorphanol
9635Normethadone
9636Norpipanone
9838Ocfentanil
9852ortho-Fluoroacryl fentanyl
9846ortho-Fluorobutyryl fentanyl
9816ortho-Fluorofentanyl
9853ortho-Fluoroisobutyryl fentanyl
9848ortho-Methyl acetylfentanyl
9820ortho-Methyl methoxyacetyl fentanyl
9826para-Chloroisobutyryl fentanyl[24]
9823para-Fluorobutyryl fentanyl
9812Para-fluorofentanyl
9854para-Fluoro furanyl fentanyl
9837para-Methoxybutyryl fentanyl
9817para-Methylfentanyl
9663PEPAP
9637Phenadoxone
9638Phenampromide
9647Phenomorphan
9641Phenoperidine
9841Benzoylfentanyl
9642Piritramide
9643Proheptazine
9644Properidine
9649Propiram[25]
9645Racemoramide
9843Tetrahydrofuranyl fentanyl
9835
9839Thiofuranyl fentanyl
9750Tilidine[26]
9646Trimeperidine
9547U-47700
9840Valerylfentanyl
9873Zipeprol[27]

Opium derivatives

Drug
9319Acetorphine
9051Acetyldihydrocodeine
9052Benzylmorphine
9070Codeine methylbromide
9053Codeine-N-Oxide
9054Cyprenorphine
9055Desomorphine
9145Dihydromorphine
9335Drotebanol[28]
9056Etorphine (except hydrochloride salt)[29]
9200Heroin
9301Hydromorphinol
9302Methyldesorphine
9304Methyldihydromorphine
9305Morphine methylbromide
9306Morphine methylsulfonate
9307Morphine-N-Oxide
9308Myrophine
9309Nicocodeine
9312Nicomorphine
9313Normorphine
9314Pholcodine
9315Thebacon

Hallucinogenic or psychedelic substances

Drug
7249α-ET[30]
73914-bromo-2,5-dimethoxy-amphetamine[31]
73922C-B[32]
73962,5-dimethoxyamphetamine (2,5-DMA)
7399DOET[33]
73482C-T-7[34]
74114-methoxyamphetamine (PMA)
74015-methoxy-3,4-methylenedioxyamphetamine (MMDA)
73954-methyl-2,5-dimethoxyamphetamine (DOM; STP)
74003,4-methylenedioxyamphetamine (MDA)
74053,4-methylenedioxymethamphetamine (MDMA)[35]
74043,4-methylenedioxy-N-ethylamphetamine (MDEA; MDE)[36]
7402N-hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy MDA)
73903,4,5-trimethoxyamphetamine (TMA)
74315-MeO-DMT[37]
7432Alpha-methyltryptamine (αMT)[38]
7433Bufotenine
7434Diethyltryptamine (DET)
7435Dimethyltryptamine (DMT)
74395-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and salts of isomers
7260Ibogaine
7315Lysergic acid diethylamide (LSD)
7360Marihuana
7381Mescaline
7374Parahexyl[39]
7415Peyote
7482N-ethyl-3-piperidyl benzilate
7484N-methyl-3-piperidyl benzilate
7437Psilocybin
7438Psilocin
7370Tetrahydrocannabinol (THC)
7455Ethylamine analog of phencyclidine (Eticyclidine; PCE)
7458Pyrrolidine analog of phencyclidine (PCPy)
7470Thiophene analog of phencyclidine (TCP)
74731-[1-(2-thienyl)cyclohexyl]pyrrolidine (TCPy)
12593-Methylmethcathinone (3-MMC)
12484-Methylmethcathinone (Mephedrone)
75353,4-methylenedioxypyrovalerone (MDPV)
75092-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)
75082-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)
75192-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)
75182-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)
73852-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)
75322-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4)
75172-(2,5-Dimethoxyphenyl)ethanamine (2C-H)
75212-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N)
75242-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)
75403,4-Methylenedioxy-N-methylcathinone (methylone)

Depressants

Drug
2010gamma-Hydroxybutyric acid (GHB; sodium oxybate; sodium oxybutyrate) except formulations in an FDA-approved drug product are Schedule III
2572Mecloqualone
2565Methaqualone

Stimulants

Drug
1585Aminorex (aminoxaphen; 2-amino-5-phenyl-2- oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine)
7493N-benzylpiperazine (some other names: BZP; 1-benzylpiperazine), its optical isomers, salts and salts of isomers
1235Cathinone
1503Fenethylline
1237Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers
1590(±)-cis-4-methylaminorex
1475N-ethylamphetamine
1480N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine)
7543N-Ethylpentylone (ephylone, N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone))[40]
7246N-Ethylhexedrone[41] (hexen)
7544alpha-Pyrrolidinohexanophenone (α-PHP)
7551alpha-Pyrrolidinoisohexanophenone (also known as α-PHiP; α-PiHP) [42]
72454-Methyl-alpha-ethylaminopentiophenone (4-MEAP)
74464'-Methyl-alpha-pyrrolidinohexiophenone (MPHP)
7548alpha-Pyrrolidinoheptaphenone (PV8)
74434-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-α-PVP)
12333-Fluoro-N-methylcathinone (3-FMC; 1-(3-fluorophenyl)-2-(methylamino)propan-1-one)
1238 4-Fluoro-N-methylcathinone (4-FMC, flephedrone, 1-(4-fluorophenyl)-2-(methylamino)propan-1-one)
1246Pentedrone (α-methylaminovalerophenone, 2-(methylamino)-1-phenylpentan-1-one)
1249 4-Methyl-N-ethylcathinone (4-MEC, 2-(ethylamino)-1-(4-methylphenyl)propan-1-one)
1258Naphyrone (naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one)
74984-Methyl-alphapyrrolidinopropiophenone (4-MePPP, MePPP, 4-methyl-α-pyrrolidinopropiophenone,1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one)
7541Butylone (bk-MBDB, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one)
7542Pentylone (bk-MBDP, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one)
7545alpha-pyrrolidinopentiophenone (α-PVP, α-pyrrolidinovalerophenone, 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one)
7546alpha-pyrrolidinobutiophenone (α-PBP, 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one)

Cannabimimetic agents

Drug
72975-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497)
72985-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog)
71181-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678)
71731-butyl-3-(1-naphthoyl)indole (JWH-073)
70191-hexyl-3-(1-naphthoyl)indole (JWH-019)
72001-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200)
62501-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250)
70811-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081)
71221-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122)
73981-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398)
72011-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201)
76941-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694)
71041-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4)
70081-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole 7008 (SR-18 and RCS-8)
72031-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203)
7144(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (UR-144, 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole)
7011[1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (5-fluoro-UR-144, 5-F-UR-144, XLR-11, 1-(5-fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole)
7048N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (APINACA, AKB-48)
7222Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (QUPIC, PB-22)[43]
7225Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22)
7012N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)
7035N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA)
7031N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA)[44]
7023N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)
7024[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201)
70342-(1-(5-Fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-ADB, 5F-MDMB-PINACA)[45]
7033 Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F-AMB)
7049 N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-APINACA, 5F-AKB48)
7010N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (ADB-FUBINACA)
7042 Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-CHMICA, MMB-CHMINACA)
7020 Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-FUBINACA)
7032N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA)[46]
7036ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-EDMB-PINACA)[47]
7041methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA)
7047N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL))
70831-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (5F-CUMYL-PINACA; SGT-25)
7014(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (FUB-144)
7021Methyl 2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate (FUB–AMB, MMB– FUBINACA, AMB–FUBINACA)
7025 5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide)
7044MMB-CHMICA (AMB-CHMICA, methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate)
7085 5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3-carboxamide)
70894-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78)
7221NM-2201 (CBL2201, Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate)
7027ADB-BUTINACA (N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butyl-1H-indazole-3-carboxamide)

See also

External links

Notes and References

  1. [Title 21 of the Code of Federal Regulations|21 CFR]
  2. United States Code via Cornell University's Legal Information Institute. Retrieved on 2007-10-02.
  3. Web site: Lawn . John . May 29, 1987 . Schedules of Controlled Substances: Placement of Alpha-Acetyl-Methylfentanyl, Alpha-methylthiofentanyl, Beta-hydroxyfentanyl, 3-Methylthiofentanyl, Para-fluorofentanyl, and Thiofentanyl into Schedule I . https://web.archive.org/web/20190728013902/https://isomerdesign.com/Cdsa/FR/52FR20070.pdf . July 28, 2019 . September 6, 2023 . Isomer Design . Drug Enforcement Administration.
  4. Web site: Bartels Jr. . John R. . June 20, 1974 . PART 1308— SCHEDULES OF CONTROLLED SUBSTANCES: Annual Publication . https://web.archive.org/web/20230906194000/https://archives.federalregister.gov/issue_slice/1974/6/20/22139-22143.pdf . September 6, 2023 . September 6, 2023 . . Drug Enforcement Administration.
  5. Web site: Rosenberg . Chuck . June 7, 2017 . Schedules of Controlled Substances: Placement of Acetyl Fentanyl Into Schedule I . September 9, 2023 . . Drug Enforcement Administration.
  6. Web site: Dhillon . Uttam . November 29, 2018 . Schedules of Controlled Substances: Placement of Furanyl Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I . September 9, 2023 . . Drug Enforcement Administration.
  7. Web site: Rosenberg . Chuck . May 16, 2016 . Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I . September 6, 2023 . . Drug Enforcement Administration.
  8. Web site: Bonner . Robert . August 18, 1993 . Schedules of Controlled Substances: Transfer of Levo-alpha-acetylmethadol from Schedule I to Schedule II . https://web.archive.org/web/20190728014110/https://isomerdesign.com/Cdsa/FR/58FR43795.pdf . July 28, 2019 . September 6, 2023 . . Drug Enforcement Administration.
  9. Web site: Mullen, Jr. . Francis M. . September 22, 1981 . Schedules of Controlled Substances: Placement of Alpha-methylfentanyl in Schedule I . https://web.archive.org/web/20190728022614/https://isomerdesign.com/Cdsa/FR/46FR46799.pdf . July 28, 2019 . September 6, 2023 . Isomer Design . Drug Enforcement Administration.
  10. Web site: Lawn . John . January 8, 1988 . Schedules of Controlled Substances: Placement of Beta-Hydroxy-3-Methylfentanyl in Schedule I . https://web.archive.org/web/20190728014034/https://isomerdesign.com/Cdsa/FR/53FR500.pdf . July 28, 2019 . September 6, 2023 . Isomer Design . Drug Enforcement Administration.
  11. Web site: Dhillon . Uttam . May 8, 2019 . Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl in Schedule I . September 9, 2023 . . Drug Enforcement Administration.
  12. Web site: Evans . D. Christopher . April 27, 2021 . Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I . September 6, 2023 . . Drug Enforcement Administration.
  13. Web site: Milgram . Anne . April 5, 2023 . Schedules of Controlled Substances: Placement of Brorphine in Schedule I . September 6, 2023 . . Drug Enforcement Administration.
  14. Web site: Patterson . Robert . April 20, 2018 . Schedules of Controlled Substances: Placement of Butyryl Fentanyl and U-47700 Into Schedule I . September 9, 2023 . . Drug Enforcement Administration.
  15. Web site: Shea . TImothy . October 2, 2020 . Schedules of Controlled Substances: Placement of Crotonyl Fentanyl in Schedule I . September 9, 2023 . . Drug Enforcement Administration.
  16. Web site: Evans . D. Christopher . March 31, 2021 . Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I; Correction . September 9, 2023 . . Drug Enforcement Administration.
  17. Web site: Dhillon . Uttam . October 25, 2019 . Schedules of Controlled Substances: Placement of Cyclopropyl Fentanyl, Methoxyacetyl fentanyl, ortho-Fluorofentanyl, and para-Fluorobutyryl Fentanyl in Schedule I . September 9, 2023 . . Drug Enforcement Administration.
  18. Web site: Jenson . Jerry . May 7, 1975 . Schedules of Controlled Substances: Placement of Difenoxin in Schedule I . https://web.archive.org/web/20190728022554/https://isomerdesign.com/Cdsa/FR/40FR19813.pdf . July 28, 2019 . September 6, 2023 . Isomer Design . Drug Enforcement Administration.
  19. Web site: Evans . D. Christopher . May 4, 2021 . Schedules of Controlled Substances: Placement of Four Specific Fentanyl-Related Substances in Schedule I . September 9, 2023 . . Drug Enforcement Administration.
  20. Web site: Milgram . Anne . November 4, 2021 . Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I . September 9, 2023 . . Drug Enforcement Administration.
  21. Web site: Milgram . Anne . August 18, 2023 . Schedules of Controlled Substances: Placement of Metonitazene in Schedule I . November 3, 2023 . . Drug Enforcement Administration.
  22. Web site: Lawn . John . January 23, 1987 . Placement of MPPP and PEPAP in Schedule I . https://web.archive.org/web/20190718193352/https://isomerdesign.com/Cdsa/FR/52FR2515.pdf . July 18, 2019 . September 9, 2023 . Isomer Design . Drug Enforcement Administration.
  23. Web site: Patterson . Robert . December 13, 2017 . Schedules of Controlled Substances: Placement of MT-45 Into Schedule I . September 9, 2023 . . Drug Enforcement Administration.
  24. Web site: Evans . D. Christopher . March 31, 2021 . Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I; Correction . September 29, 2023 . . Drug Enforcement Administration.
  25. Web site: Ingersoll . John . January 25, 1972 . Control of Propiram . https://web.archive.org/web/20190718190659/https://isomerdesign.com/Cdsa/FR/37FR1468.pdf . July 18, 2019 . September 30, 2023 . Isomer Design . Bureau of Narcotics and Dangerous Drugs.
  26. Web site: Bensinger . Peter . September 19, 1980 . Placement of Sufentanil and Tilidine in Schedule I . https://web.archive.org/web/20190728013802/https://isomerdesign.com/Cdsa/FR/45FR64571.pdf . July 28, 2019 . September 30, 2023 . Isomer Design . Drug Enforcement Administration.
  27. Web site: Milgram . Anne . November 21, 2022 . Schedules of Controlled Substances: Placement of Zipeprol in Schedule I . September 30, 2023 . . Drug Enforcement Administration.
  28. Web site: Ingersoll . John . June 27, 1972 . Control of Drotebanol . https://web.archive.org/web/20220303023117/https://isomerdesign.com/Cdsa/FR/38FR17717.pdf . March 3, 2022 . September 30, 2023 . Isomer Design . Bureau of Narcotics and Dangerous Drugs.
  29. Web site: Bartels, Jr. . John R. . March 29, 1974 . Etorphine Hydrochloride Transfer to Schedule II . https://web.archive.org/web/20220303023201/https://isomerdesign.com/Cdsa/FR/39FR11535.pdf . March 3, 2022 . September 30, 2023 . Isomer Design . Drug Enforcement Administration.
  30. Web site: Greene . Stephen . September 12, 1994 . Schedules of Controlled Substances; Placement of Alpha-Ethyltryptamine Into Schedule I . September 30, 2023 . . Drug Enforcement Administration.
  31. Web site: Bartels, Jr. . John R. . September 14, 1973 . Additions to Schedule I . https://web.archive.org/web/20220303023114/https://isomerdesign.com/Cdsa/FR/38FR26447.pdf . March 3, 2022 . September 30, 2023 . Isomer Design . Drug Enforcement Administration.
  32. Web site: Greene . Stephen . June 2, 1995 . Schedules of Controlled Substances; Placement of 4-Bromo-2,5-Dimethoxyphenethylamine Into Schedule I . September 30, 2023 . . Drug Enforcement Administration.
  33. Web site: Bonner . Robert . January 14, 1993 . Placement of Cathinone and 2,5-dimethoxy-4-ethylamphetamine (DOET) into Schedule I . https://web.archive.org/web/20210926005615/https://isomerdesign.com/Cdsa/FR/58FR4316.pdf . September 26, 2021 . November 3, 2023 . Isomer Design . Drug Enforcement Administration.
  34. Web site: Leonhart . Michele . March 18, 2004 . Schedules of Controlled Substances; Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine Into Schedule I of the Controlled Substances Act . November 3, 2023 . . Drug Enforcement Administration.
  35. Web site: Lawn . John . February 22, 1988 . Scheduling of 3,4-methylenedioxymethamphetamine (MDMA) into Schedule I of the Controlled Substances Act; Remand . live . https://web.archive.org/web/20220303023212/https://isomerdesign.com/Cdsa/FR/53FR5156.pdf . March 3, 2022 . November 3, 2023 . Isomer Design . Drug Enforcement Administration.
  36. Web site: Lawn . John . April 13, 1989 . Placement of 3,4-Methylenedioxy-N-ethylamphetamine and N-hydroxy-3,4-methylenedioyamphetamine into Schedule I . live . https://web.archive.org/web/20220303023243/https://isomerdesign.com/Cdsa/FR/54FR14797.pdf . March 3, 2022 . August 3, 2024 . Isomer Design . Drug Enforcement Administration.
  37. Web site: Leonhart . Michele . December 20, 2010 . Placement of 5-Methoxy-N,N-Dimethyltryptamine into Schedule I of the Controlled Substances Act . August 3, 2024 . . Drug Enforcement Administration.
  38. Web site: Leonhart . Michele . September 29, 2004 . Placement of Alpha-Methyltryptamine and 5-Methoxy-N,N-Diisopropyltryptamine Into Schedule I of the Controlled Substances Act . August 3, 2024 . . Drug Enforcement Administration.
  39. Web site: Lawn . John . November 22, 1982 . Placement of Parahexyl into Schedule I . https://web.archive.org/web/20240519095915/https://isomerdesign.com/Cdsa/FR/47FR52432.pdf . May 19, 2024 . August 3, 2024 . Isomer Design . Drug Enforcement Administration.
  40. Web site: Schedules of Controlled Substances: Temporary Placement of N-Ethylpentylone in Schedule I . Drug Enforcement Administration .
  41. Web site: Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I . Drug Enforcement Administration .
  42. Web site: Specific Listing for Three Currently Controlled Schedule I Substances . Federal Register . DEA . 27 January 2024.
  43. 24605391 . Fed. Regist. . Feb 10, 2014 . 79 . 27 . 7577–7582 . Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order . Drug Enforcement Administration . Department of Justice .
  44. 25730924. 2015. Drug Enforcement Administration. Department of Justice. Schedules of controlled substances: Temporary placement of three synthetic cannabinoids into schedule I. Final order. Federal Register. 80. 20. 5042–7.
  45. Web site: Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) Into Schedule I . Drug Enforcement Administration.
  46. 29461023. 2018. Drug Enforcement Administration. Department of Justice. Schedules of Controlled Substances: Extension of Temporary Placement of MAB–CHMINACA in Schedule I of the Controlled Substances Act. Temporary rule; temporary scheduling order; extension. Federal Register. 83. 20. 4411–2.
  47. Web site: Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I . Federal Register .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "List of Schedule I controlled substances (U.S.)".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.